Skip to main content

You are here

News & Insights

IGEM Therapeutics

Epsilogen Announces £3m Series A2 financing and licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London

Epsilogen Ltd (formerly known as IGEM Therapeutics), a global leader in the development of immunoglobulin E (IgE) antibodies to...

AstronauTx secures UCLTF investment for dementia therapeutics

AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of astrocytes for the...

Portfolio company Astroscreen featured in the Evening Standard

As the UK gears up for a potential election, there are concerns over the role disinformation will play in democracy

October 17, 2019

Quell Therapeutics makes FierceBiotech's 2019 Fierce 15

The list highlights biotech companies whose hard work and cutting-edge research aims to stop disease in its tracks.

September 23, 2019

Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment

Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease...

September 16, 2019

Why we Invested in Quantum Computing start-up Phasecraft

There has been a leap in excitement about quantum computing in the last year thanks to the emergence of a new class of quantum...

September 09, 2019

Achilles Therapeutics raises £100m in Series B

Achilles Therapeutics (“Achilles”), a bio-pharmaceutical company developing personalised cancer immunotherapies, today announces...

September 04, 2019

Orchard Therapeutics Announces Update from POC Study of OTL-203

Orchard Therapeutics announced data from an ongoing proof-of-concept clinical trial evaluating the safety and efficacy of OTL-203...

September 04, 2019

UCL’s Centre for Amyloidosis and Acute Phase Proteins published in the Journal of Medicinal Chemistry

Ground-breaking work by Prof Alessandra Corazza, Prof Sir Mark Pepys, Prof Vittorio Bellotti and colleagues of the Wolfson Drug...

August 27, 2019

Funding academic innovations in advanced therapies: an interview with Simon Goldman

Simon Goldman, Investment Manager for UCLTF, talks to RegMedNet about funding academic innovation

August 01, 2019

UCL Technology Fund Brochure

2019 Brochure

Featuring fund highlights from the past year

Andrew Elder on healthtech investing

Andrew Elder talks to HS. about his journey from brain surgeon to venture capitalist, the history of healthtech investing and how...

UCL Technology Fund Showcase 2019

We would like to thank everyone who attended the 2019 UCL Technology Fund showcase. We hope the event provided some insight on...

Hazy wins 'Best Innovation in Data Protection & Privacy'

Hazy wins 'Best Innovation in Data Protection & Privacy' at the 2019 CogX awards.

quantum computing

Fund leads £750k investment in Phasecraft

The UCL Technology Fund led a £750k investment into Phasecraft, a pioneering quantum computing company, along with co-investors...

Quell Therapeutics UCLTF

UCLTF completes £1m investment into Quell Therapeutics as part of £35m Series A round

UCLTF £1m investment into Quell Therapeutics is part of a £35m Series A round led by Syncona

GUV Award

UCLTF nominated for 'Investment Unit of the Year'

We are delighted to announce that the UCL Technology Fund has been nominated for Investment Unit of the Year by Global University...

Odin Team

Odin Vision scales up its cancer detection technology

Innovative medtech company Odin Vision is to scale up its pioneering cancer detection technology thanks to an investment round...

Astroscreen

Astroscreen raises $1m to detect social media manipulation

UK-based start-up Astroscreen has secured $1M in initial funding to progress its pioneering technology which identifies carriers...

Orchard Therapeutics

Data Supports Achievement of Proof-of-Concept Milestone for OTL-300

Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from the trial of OTL-300, for the...

Orchard Therapeutics

Orchard Therapeutics achieves 100% survival rate during trial treatment for ADA-SCID

Orchard Therapeutics, a commercial-stage biopharmaceutical company, presented their two-year follow-up data in 20 patients from...

February 28, 2019

Hazy

Hazy included in Forbes '15 Machine Learning Companies To Watch In Europe'

Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch.

December 03, 2018

IGEM Therapeutics UCLF

IGEM Therapeutics Announces Final Close of £5m Series A Financing Round

New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE...

November 30, 2018

Orchard Therapeutics

Orchard Therapeutics announces closing of $225 Million Initial Public Offering

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through...

November 05, 2018

Hazy Team Photo

UCL spin-out Hazy adds $1.8 million in seed funding

Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has...

August 01, 2018

MeiraGTx

UCL Technology Fund investment MeiraGTx raises $75m at IPO

MeiraGTx is its first UCLTF investment to IPO

BloomsburyAI

Bloomsbury AI joins the Facebook Team in London

UCL Technology Fund is very proud to have backed Bloomsbury AI and we are delighted that they are joining the Facebook team.

Matr image of teacher and children.JPG

Matr raises £4.75 million for AI teaching platform

Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL...

Freeline therapeutics.jpeg

Freeline secures over £88 million of funding

Freeline Therapeutics announces today that it has raised over £88 million of new capital in a Series B financing round

UCLTF Showcase 2018

UCL Technology Fund Showcase 2018

The inaugural UCL Technology Fund Showcase, held at Digital Catapult, brought together two years of investing in world-leading...

Glialign

UCL Technology Fund invests in cell therapy company Glialign

The UCL Technology Fund, UK Innovation & Science Seed Fund, alongside support from Innovate UK, have invested in UCL spinout...

Mediagamma2

UCL Technology Fund and ParkWalk invest in adtech machine learning company MediaGamma

The UCL Technology Fund has invested in MediaGamma, the predictive analytics software company, as part of a £2m round in...

February 26, 2018

p47-CGD

UCL Technology Fund has approved investment of up to £1m in the development of a gene therapy for p47-CGD

The UCL Technology Fund has approved an investment of up to £1m to support the development of a gene therapy for p47phox-...

Canbex

UCLTF fund drug development platform Canbex for the treatment of multiple sclerosis

Canbex was established to develop the VSN compound series, a drug development platform with potential applications in a wide...

January 16, 2017

Orchard Therapeutics

Orchard Therapeutics launches with £21-million series A funding round

Orchard Therapeutics has secured £21-million in Series A financing led by F-Prime with UCLTF. Orchard Therapeutics is a...

AlbionVC to manage UCLTF fund

Albion to Manage the UCL Technology Fund

Albion Capital, one of the largest independent venture capital investors in the UK is to manage and administer the newly launched...

January 18, 2016